There have been 50 recent insider transactions recorded for DBV Technologies S.A. (DBVT), including 24 buys and 18 sells. Total insider buying was valued at $9.68M and total insider selling at $5.67M.
Notable insiders with recent activity include Mohideen Pharis, Baker Bros. Advisors Lp, Epic Bpifrance. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — DBVT
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-01-29 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
534 |
$4.86 |
$2.6K |
144,995 |
| 2026-01-12 |
Baker Bros. Advisors Lp |
Director |
Option Exercise (Sell) |
25,005,240 |
- |
- |
- |
| 2025-12-18 |
Epic Bpifrance |
Other: Member of 10% Owner Group |
Informative Sell |
1,292,103 |
$4.19 |
$5.41M |
7,303,369 |
| 2025-12-17 |
Epic Bpifrance |
Other: Member of 10% Owner Group |
Informative Sell |
40,000 |
$5.28 |
$211.2K |
8,595,472 |
| 2025-11-21 |
Tasse Daniel |
Chief Executive Officer |
RSU Award |
964,000 |
$2.90 |
$2.8M |
964,000 |
| 2025-11-21 |
Boucinha Virginie |
Chief Financial Officer |
RSU Award |
32,000 |
- |
- |
70,000 |
| 2025-11-21 |
Trapp Kevin Michael |
Chief Commercial Officer |
RSU Award |
55,000 |
- |
- |
55,000 |
| 2025-11-21 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
1,624 |
$2.77 |
$4.5K |
101,529 |
| 2025-11-20 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
6,496 |
$2.88 |
$18.71K |
103,153 |
| 2025-11-03 |
Trapp Kevin Michael |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-07-29 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
464 |
$2.22 |
$1.03K |
109,649 |
| 2025-05-22 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
397 |
$1.84 |
$730.48 |
110,113 |
| 2025-04-07 |
Bpifrance Sa |
10 Percent Owner |
Unknown |
6,556,781 |
- |
- |
- |
| 2025-04-07 |
Epic Bpifrance |
Other: Member of 10% Owner Group |
Unknown |
6,556,781 |
- |
- |
- |
| 2025-03-27 |
Baker Bros. Advisors Lp |
10 Percent Owner |
RSU Award |
2,299,656 |
- |
- |
2,299,656 |
| 2025-03-27 |
Bpifrance Sa |
10 Percent Owner |
Unknown |
- |
- |
- |
226,133 |
| 2025-03-27 |
Bpifrance Investissement S.a.s. |
Other: Member of 10% Owner Group |
Unknown |
- |
- |
- |
226,133 |
| 2025-03-27 |
Epic Bpifrance |
Other: Member of 10% Owner Group |
Unknown |
- |
- |
- |
226,133 |
| 2025-01-30 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
600 |
$0.85 |
$510.00 |
110,510 |
| 2024-12-04 |
Tasse Daniel |
Chief Executive Officer |
RSU Award |
813,200 |
$0.89 |
$723.75K |
813,200 |
| 2024-11-25 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
565 |
$0.57 |
$322.05 |
111,110 |
| 2024-11-22 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
342 |
$0.53 |
$181.26 |
111,675 |
| 2024-11-21 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
2,350 |
$0.54 |
$1.27K |
112,017 |
| 2024-11-21 |
Boucinha Virginie |
Chief Financial Officer |
RSU Award |
19,000 |
- |
- |
38,000 |
| 2024-07-29 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
1,785 |
$0.98 |
$1.75K |
79,367 |
| 2024-05-24 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
660 |
$1.36 |
$897.60 |
81,152 |
| 2024-05-22 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
382 |
$1.38 |
$527.16 |
81,812 |
| 2024-03-08 |
Tasse Daniel |
Chief Executive Officer |
Informative Buy |
17,094 |
$0.83 |
$14.19K |
17,094 |
| 2024-02-06 |
Ndu Adora |
Director |
Informative Buy |
1,825 |
$0.89 |
$1.62K |
1,825 |
| 2023-11-22 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
2,245 |
$1.74 |
$3.91K |
82,194 |
| 2023-11-20 |
Tasse Daniel |
Chief Executive Officer |
RSU Award |
806,672 |
$2.19 |
$1.77M |
806,672 |
| 2023-11-20 |
Mohideen Pharis |
Chief Medical Officer |
RSU Award |
35,000 |
- |
- |
84,439 |
| 2023-11-20 |
Boucinha Virginie |
Chief Financial Officer |
RSU Award |
19,000 |
- |
- |
19,000 |
| 2023-11-06 |
Boucinha Virginie |
Officer |
Unknown |
- |
- |
- |
- |
| 2023-08-25 |
Morris Timothy E |
Director |
Informative Buy |
12,000 |
$1.52 |
$18.24K |
12,000 |
| 2023-08-01 |
Soland Daniel B |
Director |
Informative Buy |
15,000 |
$1.62 |
$24.3K |
20,000 |
| 2023-05-24 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
469 |
$3.54 |
$1.66K |
49,439 |
| 2022-11-24 |
Mohideen Pharis |
Chief Medical Officer |
Informative Sell |
1,792 |
$2.88 |
$5.16K |
49,908 |
| 2022-11-21 |
Tasse Daniel |
Chief Executive Officer |
RSU Award |
764,386 |
$3.07 |
$2.35M |
764,386 |
| 2022-11-21 |
Mohideen Pharis |
Chief Medical Officer |
RSU Award |
17,500 |
- |
- |
51,700 |
| 2022-11-21 |
Robitaille Sebastien |
Chief Financial Officer |
RSU Award |
8,000 |
- |
- |
36,500 |
| 2022-10-03 |
Guyot-caparros Daniele |
Director |
Unknown |
- |
- |
- |
- |
| 2022-07-29 |
Mohideen Pharis |
Chief Medical Officer |
RSU Award |
10,000 |
- |
- |
34,200 |
| 2022-06-13 |
Baker Bros. Advisors Lp |
10 Percent Owner |
RSU Award |
1,383,352 |
- |
- |
1,383,352 |
| 2022-06-13 |
Baker Brothers Life Sciences Lp |
Director |
RSU Award |
1,383,352 |
- |
- |
1,383,352 |
| 2021-11-22 |
Tasse Daniel |
Chief Executive Officer |
RSU Award |
274,000 |
$6.62 |
$1.81M |
274,000 |
| 2021-11-22 |
Mohideen Pharis |
Chief Medical Officer |
RSU Award |
8,700 |
- |
- |
24,200 |
| 2021-11-22 |
Robitaille Sebastien |
Chief Financial Officer |
RSU Award |
5,000 |
- |
- |
28,500 |
| 2021-06-10 |
De Rosen Michel |
Director |
Informative Buy |
6,837 |
$13.09 |
$89.5K |
6,837 |
| 2021-06-10 |
Morris Timothy E |
Director |
Informative Buy |
6,837 |
$13.09 |
$89.5K |
6,837 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
